Surface Oncology Banks $119.5 Million With IPO and Private Placement

Surface Oncology announced on 4/23/18 the closing of its initial public offering of 7,200,000 shares of common stock at a public offering price of $15.00 per share. The gross proceeds from the offering were $108.0 million. In addition, Surface has granted the underwriters a 30-day option to purchase up to 1,080,000 additional shares of common stock at the initial public offering price, less the underwriting discount. Surface’s common stock began trading on the Nasdaq Global Market under the ticker symbol “SURF” on April 19, 2018.